A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients

NCT01726348 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The company decided to cancel this study in conformity with PH FDA Circular 2013-004

Conditions

Interventions

Sponsor

Janssen Pharmaceutica